AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 30380365 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimally invasive surgery
Number of subjects: 631
Study 28303520 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-procedural cortisol assay (IRCA) guiding adrenal vein sampling
Number of subjects: 200
Study 28303520 — intervention group
Group type: COMPARATOR
Intervention: Usual practice AVS without IRCA
Number of subjects: 200
Study 25430915 — intervention group
Group type: EXPERIMENTAL
Intervention: Fascia iliaca block (FIB)
Number of subjects: 178
Study 25430915 — intervention group
Group type: COMPARATOR
Intervention: 3-in-1 block
Number of subjects: 178
Study 23254217 — intervention group
Group type: EXPERIMENTAL
Intervention: Coping motives for drinking
Number of subjects: 50
Study 23254217 — intervention group
Group type: EXPERIMENTAL
Intervention: Low levels of adaptive coping
Number of subjects: 50
Study 23254217 — intervention group
Group type: EXPERIMENTAL
Intervention: High and low levels of adaptive coping
Number of subjects: 50
Study 23254217 — intervention group
Group type: EXPERIMENTAL
Intervention: Adaptive coping and coping motives interaction
Number of subjects: 50
Study 21909472 — intervention group
Group type: EXPERIMENTAL
Intervention: β‐calcium pyrophosphate (β‐CPP) plus autograft
Number of subjects: 31
Study 21909472 — intervention group
Group type: COMPARATOR
Intervention: Autograft alone
Number of subjects: 31
Study 18269664 — intervention group
Group type: EXPERIMENTAL
Intervention: Tacrolimus 0.1% ointment
Number of subjects: 32
Study 18269664 — intervention group
Group type: COMPARATOR
Intervention: Clobetasol 0.05% ointment
Number of subjects: 32
Study 17172892 — intervention group
Group type: EXPERIMENTAL
Intervention: Fibrin tissue adhesive (Quixil; n = 39)
Number of subjects: 65
Study 17172892 — intervention group
Group type: COMPARATOR
Intervention: 8‐0 Vicryl absorbable interrupted sutures (n = 26)
Number of subjects: 65
Study 12735496 — intervention group
Group type: EXPERIMENTAL
Intervention: Mixed discrete and continuous Cox regression model
Number of subjects: 0
Study 10795655 — intervention group
Group type: EXPERIMENTAL
Intervention: acrivastine‐pseudoephedrine
Number of subjects: 593
Study 10795655 — intervention group
Group type: EXPERIMENTAL
Intervention: loratadine‐pseudoephedrine
Number of subjects: 593
Study 10795655 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 593
Study 8624625 — intervention group
Group type: EXPERIMENTAL
Intervention: Piroxicam 20 mg once daily
Number of subjects: 65
Study 8624625 — intervention group
Group type: COMPARATOR
Intervention: Tenoxicam 20 mg once daily
Number of subjects: 65
Study 8624625 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions combined
Number of subjects: 65
Study 1458892 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose oral contraceptive containing 0.15 mg LNG and 0.03 mg EE2 (Microgynon)
Number of subjects: 9
Study 1458892 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose oral contraceptive (Microgynon)
Number of subjects: 9
Study 1458892 — intervention group
Group type: COMPARATOR
Intervention: Single dose administration of the same formulation
Number of subjects: 9
Study 2935811 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisone-azathioprine-low dose cyclosporin A (8 mg/kg)
Number of subjects: 46
Study 2935811 — intervention group
Group type: COMPARATOR
Intervention: Conventional regimen (corticosteroid-azathioprine-antilymphocyte globulin)
Number of subjects: 46
Study 31948327 — intervention group
Group type: EXPERIMENTAL
Intervention: Hand hygiene training program for parents and kindergarteners; duration: 4 weeks; kindergarteners attended 45-minute sessions, parents attended 1-hour sessions.
Number of subjects: 0
Study 30863254 — intervention group
Group type: EXPERIMENTAL
Intervention: ColActive plus Ag dressing
Number of subjects: 25
Study 30863254 — intervention group
Group type: COMPARATOR
Intervention: Traditional dressing (Vaseline and Nitrofurazone)
Number of subjects: 25
Study 27511027 — intervention group
Group type: EXPERIMENTAL
Intervention: Anteromedial portal (AMP) technique
Number of subjects: 36
Study 27511027 — intervention group
Group type: COMPARATOR
Intervention: Transtibial (TT) technique
Number of subjects: 36
Study 25642640 — intervention group
Group type: EXPERIMENTAL
Intervention: Dancing Group (DG)
Number of subjects: 34
Study 24016345 — intervention group
Group type: EXPERIMENTAL
Intervention: Femtosecond laser refractive lens surgery
Number of subjects: 20
Study 22060186 — intervention group
Group type: EXPERIMENTAL
Intervention: Wild blueberry drink
Number of subjects: 0
Study 22060186 — intervention group
Group type: COMPARATOR
Intervention: Placebo drink
Number of subjects: 0
Study 18489633 — intervention group
Group type: EXPERIMENTAL
Intervention: Methadone
Number of subjects: 140
Study 18489633 — intervention group
Group type: EXPERIMENTAL
Intervention: Benzodiazepines
Number of subjects: 140
Study 18489633 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall sleep apnea severity
Number of subjects: 140
Study 18489633 — intervention group
Group type: COMPARATOR
Intervention: No intervention
Number of subjects: 140
Study 16949966 — intervention group
Group type: EXPERIMENTAL
Intervention: Middle ear surgery
Number of subjects: 33
Study 16949966 — intervention group
Group type: COMPARATOR
Intervention: Control group (volunteers)
Number of subjects: 33
Study 15293492 — intervention group
Group type: EXPERIMENTAL
Intervention: ESUS (extended stroke unit service)
Number of subjects: 320
Study 15293492 — intervention group
Group type: COMPARATOR
Intervention: OSUS (ordinary stroke unit service)
Number of subjects: 320
Study 11759643 — intervention group
Group type: EXPERIMENTAL
Intervention: Nephrectomy followed by interferon alfa-2b
Number of subjects: 241
Study 11759643 — intervention group
Group type: COMPARATOR
Intervention: Interferon alfa-2b alone
Number of subjects: 241
Study 9203880 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol anaesthesia
Number of subjects: 40
Study 9203880 — intervention group
Group type: COMPARATOR
Intervention: Inhalational anaesthesia
Number of subjects: 40
Study 7949091 — intervention group
Group type: EXPERIMENTAL
Intervention: Low levels of factor VII (FVII) in homozygous FVII-deficient patients
Number of subjects: 33
Study 3422792 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupivacaine plus diflunisal (500 mg)
Number of subjects: 26
Study 3422792 — intervention group
Group type: COMPARATOR
Intervention: Lidocaine plus diflunisal (500 mg)
Number of subjects: 26
Study 31626067 — intervention group
Group type: EXPERIMENTAL
Intervention: Take a Stand! intervention
Number of subjects: 0
Study 31626067 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 28646527 — intervention group
Group type: EXPERIMENTAL
Intervention: Dentalvibe® (DV) - buccal and palatal infiltration on the maxilla and inferior alveolar nerve block (IANB) with vibration
Number of subjects: 40
Study 28646527 — intervention group
Group type: COMPARATOR
Intervention: Traditional method (TR) - same injections without vibration
Number of subjects: 40
Study 27349592 — intervention group
Group type: EXPERIMENTAL
Intervention: Fibrin sealant
Number of subjects: 20
Study 27349592 — intervention group
Group type: COMPARATOR
Intervention: Suture (buried 6-0 Vicryl)
Number of subjects: 20
Study 24836354 — intervention group
Group type: EXPERIMENTAL
Intervention: Mixed-meal tolerance test
Number of subjects: 58
Study 24836354 — intervention group
Group type: EXPERIMENTAL
Intervention: C-peptide measurement using chemiluminescent immunoassay
Number of subjects: 58
Study 22210578 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle intervention
Number of subjects: 443
Study 22210578 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 443
Study 20350952 — intervention group
Group type: EXPERIMENTAL
Intervention: ASA 500 mg/PSE 30 mg
Number of subjects: 640
Study 20350952 — intervention group
Group type: EXPERIMENTAL
Intervention: ASA 1000 mg/PSE 60 mg
Number of subjects: 640
Study 20350952 — intervention group
Group type: COMPARATOR
Intervention: APAP 1000 mg/PSE 60 mg
Number of subjects: 640
Study 18245404 — intervention group
Group type: EXPERIMENTAL
Intervention: Atomoxetine (1.2 mg/kg per day)
Number of subjects: 226
Study 18245404 — intervention group
Group type: EXPERIMENTAL
Intervention: Atomoxetine
Number of subjects: 226
Study 18245404 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 226
Study 15007599 — intervention group
Group type: EXPERIMENTAL
Intervention: Scanner-assisted CO2 laser microincision
Number of subjects: 155
Study 15007599 — intervention group
Group type: COMPARATOR
Intervention: Manually guided CO2 laser microincision (Acuspot micromanipulator)
Number of subjects: 155
Study 14608246 — intervention group
Group type: EXPERIMENTAL
Intervention: Citalopram
Number of subjects: 58
Study 14608246 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertraline
Number of subjects: 58
Study 14608246 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 58
Study 10754373 — intervention group
Group type: EXPERIMENTAL
Intervention: H. pylori positive
Number of subjects: 66
Study 10754373 — intervention group
Group type: COMPARATOR
Intervention: H. pylori negative
Number of subjects: 66
Study 8926225 — intervention group
Group type: EXPERIMENTAL
Intervention: Enforcement schedules of 2 months
Number of subjects: 0
Study 8926225 — intervention group
Group type: EXPERIMENTAL
Intervention: Enforcement schedules of 4 months
Number of subjects: 0
Study 8926225 — intervention group
Group type: EXPERIMENTAL
Intervention: Enforcement schedules of 6 months
Number of subjects: 0
Study 8926225 — intervention group
Group type: COMPARATOR
Intervention: Control condition (no enforcement)
Number of subjects: 0
Study 1949926 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-Controlled Analgesia (PCA)
Number of subjects: 6
Study 1949926 — intervention group
Group type: COMPARATOR
Intervention: Intramuscular (IM) dosing
Number of subjects: 6
Study 6547808 — intervention group
Group type: COMPARATOR
Intervention: Cookies with 20 g of Fusarium graminearium
Number of subjects: 150
Study 6547808 — intervention group
Group type: COMPARATOR
Intervention: Cupcakes with 10 g of Paecilomyces variotii
Number of subjects: 150
Study 6547808 — intervention group
Group type: COMPARATOR
Intervention: Milk (control for nutritive value studies)
Number of subjects: 150
Study 6547808 — intervention group
Group type: EXPERIMENTAL
Intervention: Fusarium graminearium (nutritive value)
Number of subjects: 150
Study 6547808 — intervention group
Group type: EXPERIMENTAL
Intervention: Paecilomyces variotii (nutritive value)
Number of subjects: 150
Study 31732062 — intervention group
Group type: EXPERIMENTAL
Intervention: Yacon syrup (40g, 14g of FOS)
Number of subjects: 40
Study 31732062 — intervention group
Group type: COMPARATOR
Intervention: Placebo (40g)
Number of subjects: 40
Study 29653651 — intervention group
Group type: EXPERIMENTAL
Intervention: 7F sheathless guide catheter
Number of subjects: 41
Study 29653651 — intervention group
Group type: COMPARATOR
Intervention: 6F sheath/guide combination
Number of subjects: 41
Study 26678873 — intervention group
Group type: EXPERIMENTAL
Intervention: C15:0
Number of subjects: 1180
Study 26678873 — intervention group
Group type: EXPERIMENTAL
Intervention: C17:0
Number of subjects: 1180
Study 1427246 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise and cognitive-behavioral programs
Number of subjects: 230
Study 1427246 — intervention group
Group type: COMPARATOR
Intervention: Discussion control program
Number of subjects: 230
Study 22814748 — intervention group
Group type: EXPERIMENTAL
Intervention: GW501516 10 mg
Number of subjects: 268
Study 22814748 — intervention group
Group type: EXPERIMENTAL
Intervention: GW501516 5 mg and 10 mg (exploratory study)
Number of subjects: 268
Study 20642768 — intervention group
Group type: EXPERIMENTAL
Intervention: alpha-bisabolol-containing cream applied once a day for 8 weeks
Number of subjects: 28
Study 20642768 — intervention group
Group type: COMPARATOR
Intervention: vehicle control cream
Number of subjects: 28
Study 19216199 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 15791171 — intervention group
Group type: EXPERIMENTAL
Intervention: Methohexital alone (80-100 mg IV bolus)
Number of subjects: 110
Study 15791171 — intervention group
Group type: COMPARATOR
Intervention: Remifentanil (500 mcg IV bolus) with low-dose methohexital (40 mg IV)
Number of subjects: 110
Study 12460132 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-reported cannabis use
Number of subjects: 248
Study 12460132 — intervention group
Group type: COMPARATOR
Intervention: On-site qualitative urine screening
Number of subjects: 248
Study 12460132 — intervention group
Group type: COMPARATOR
Intervention: Laboratory testing
Number of subjects: 248
Study 12460132 — intervention group
Group type: EXPERIMENTAL
Intervention: Kappa coefficients
Number of subjects: 248
Study 12460132 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive urine tests
Number of subjects: 248
Study 10505742 — intervention group
Group type: EXPERIMENTAL
Intervention: sIL‐2R
Number of subjects: 35
Study 10505742 — intervention group
Group type: EXPERIMENTAL
Intervention: sTNFR
Number of subjects: 35
Study 10505742 — intervention group
Group type: EXPERIMENTAL
Intervention: IL‐1beta
Number of subjects: 35
Study 10505742 — intervention group
Group type: EXPERIMENTAL
Intervention: IL‐2
Number of subjects: 35
Study 10505742 — intervention group
Group type: EXPERIMENTAL
Intervention: IL‐8
Number of subjects: 35
Study 10505742 — intervention group
Group type: EXPERIMENTAL
Intervention: TNF‐alpha
Number of subjects: 35
Study 9198431 — intervention group
Group type: EXPERIMENTAL
Intervention: IAN block + IO injection (2% lidocaine with 1:100,000 epinephrine)
Number of subjects: 40
Study 9198431 — intervention group
Group type: COMPARATOR
Intervention: IAN block (mock IO injection)
Number of subjects: 40
Study 9198431 — intervention group
Group type: EXPERIMENTAL
Intervention: IO injection
Number of subjects: 40
Study 1761896 — intervention group
Group type: EXPERIMENTAL
Intervention: Rokitamycin (RKM) 600 mg daily for 5 days
Number of subjects: 90
Study 1761896 — intervention group
Group type: COMPARATOR
Intervention: Ofloxacin (OFLX) 600 mg daily for 5 days
Number of subjects: 90
Study 3880670 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril
Number of subjects: 35
Study 30803141 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-oral camera (IOC)
Number of subjects: 142
Study 30803141 — intervention group
Group type: EXPERIMENTAL
Intervention: Text messages (TM)
Number of subjects: 142
Study 30803141 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-oral camera (IOC) + Text messages (TM)
Number of subjects: 142
Study 30803141 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 142
Study 29950229 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose dexamethasone + bortezomib + thalidomide (Group A)
Number of subjects: 96
Study 29950229 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose dexamethasone + bortezomib + thalidomide (Group B)
Number of subjects: 96
Study 29950229 — intervention group
Group type: COMPARATOR
Intervention: Placebo + bortezomib + thalidomide (Group C)
Number of subjects: 96
Study 26558356 — intervention group
Group type: EXPERIMENTAL
Intervention: IV‐PCA with propacetamol (4 g)
Number of subjects: 108
Study 26558356 — intervention group
Group type: COMPARATOR
Intervention: IV‐PCA with normal saline mixed to fentanyl (20 μg/kg)
Number of subjects: 108
Study 25301463 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous serelaxin for 48 hours
Number of subjects: 1161
Study 25301463 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1161
Study 22707187 — intervention group
Group type: EXPERIMENTAL
Intervention: Zofenopril (60 mg/day) plus ASA (100 mg/day)
Number of subjects: 771
Study 22707187 — intervention group
Group type: COMPARATOR
Intervention: Ramipril (10 mg/day) plus ASA (100 mg/day)
Number of subjects: 771
Study 20540652 — intervention group
Group type: EXPERIMENTAL
Intervention: pioglitazone (15-30 mg/day) plus conventional oral hypoglycemic agents
Number of subjects: 63
Study 20540652 — intervention group
Group type: COMPARATOR
Intervention: conventional oral hypoglycemic agents alone
Number of subjects: 63
Study 21385259 — intervention group
Group type: EXPERIMENTAL
Intervention: Information sessions for recruitment
Number of subjects: 269
Study 21385259 — intervention group
Group type: COMPARATOR
Intervention: Women with legal guardians
Number of subjects: 269
Study 21385259 — intervention group
Group type: COMPARATOR
Intervention: Women without legal guardians
Number of subjects: 269
Study 16048218 — intervention group
Group type: EXPERIMENTAL
Intervention: TenderWet 24
Number of subjects: 42
Study 16048218 — intervention group
Group type: COMPARATOR
Intervention: Iruxol N (Santyl)
Number of subjects: 42
Study 12450902 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium-fortified orange juice
Number of subjects: 12
Study 12450902 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium carbonate supplement
Number of subjects: 12
Study 12450902 — intervention group
Group type: EXPERIMENTAL
Intervention: Skim milk
Number of subjects: 12
Study 12450902 — intervention group
Group type: EXPERIMENTAL
Intervention: High-calcium diet (1300 mg/d)
Number of subjects: 12
Study 12450902 — intervention group
Group type: COMPARATOR
Intervention: Low-calcium diet (300 mg/d)
Number of subjects: 12
Study 9838127 — intervention group
Group type: EXPERIMENTAL
Intervention: FGF-9 immunoreactivity in Alzheimer's disease (AD) brains
Number of subjects: 0
Study 9838127 — intervention group
Group type: COMPARATOR
Intervention: FGF-9 immunoreactivity in control cases
Number of subjects: 0
Study 9838127 — intervention group
Group type: EXPERIMENTAL
Intervention: FGF-9 immunoreactive astrocytes in AD brains
Number of subjects: 0
Study 9838127 — intervention group
Group type: EXPERIMENTAL
Intervention: Amyloid core and neurofibrillary tangles
Number of subjects: 0
Study 8033503 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-desamino-8-D-vasopressin
Number of subjects: 9
Study 8033503 — intervention group
Group type: COMPARATOR
Intervention: Indocyanine Green clearance
Number of subjects: 9
Study 2610781 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine care plus one‐to‐one support by an experienced monitrice
Number of subjects: 103
Study 2610781 — intervention group
Group type: COMPARATOR
Intervention: Routine nursing care (controls)
Number of subjects: 103
Study 29504416 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressive resistance training (PRT), n=28, 12 weeks, 3 times a week, 2 sets of 15-20 repetitions
Number of subjects: 52
Study 29504416 — intervention group
Group type: COMPARATOR
Intervention: Control (CON), n=24, sham-exercise with active mobilization
Number of subjects: 52
Study 28703936 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous tibial nerve stimulation (PTNS)
Number of subjects: 59
Study 28703936 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 59
Study 26132356 — intervention group
Group type: EXPERIMENTAL
Intervention: Wheelie training on a ramp (ramp group)
Number of subjects: 52
Study 26132356 — intervention group
Group type: COMPARATOR
Intervention: Conventional training (conventional group)
Number of subjects: 52
Study 22946966 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-dose (SD) antibiotic prophylaxis with second-generation cephalosporin and metronidazole
Number of subjects: 93
Study 22946966 — intervention group
Group type: COMPARATOR
Intervention: Three-dose (MD) antibiotic prophylaxis with second-generation cephalosporin and metronidazole
Number of subjects: 93
Study 22946966 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-dose (SD) antibiotic prophylaxis
Number of subjects: 93
Study 22946966 — intervention group
Group type: COMPARATOR
Intervention: Three-dose (MD) antibiotic prophylaxis
Number of subjects: 93
Study 21082476 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced infant mental health oriented case management services
Number of subjects: 144
Study 21082476 — intervention group
Group type: COMPARATOR
Intervention: Control group (no enhanced case management)
Number of subjects: 144
Study 18583047 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral opioids (OP)
Number of subjects: 110
Study 18583047 — intervention group
Group type: COMPARATOR
Intervention: Non-opioid analgesics (NOP)
Number of subjects: 110
Study 16646121 — intervention group
Group type: EXPERIMENTAL
Intervention: Computerized neuropsychological rehabilitation (NR), 10-session adjunctive program
Number of subjects: 19
Study 16646121 — intervention group
Group type: COMPARATOR
Intervention: Standard substance abuse treatment (no adjunctive NR)
Number of subjects: 19
Study 14564328 — intervention group
Group type: EXPERIMENTAL
Intervention: Clopidogrel and aspirin combination (C+A)
Number of subjects: 50
Study 14564328 — intervention group
Group type: COMPARATOR
Intervention: Aspirin alone (A)
Number of subjects: 50
Study 11128566 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-fluorouracil (5FU) and leucovorin (LCV) - dose intense regimen (biweekly)
Number of subjects: 47
Study 11128566 — intervention group
Group type: COMPARATOR
Intervention: 5-fluorouracil (5FU) and leucovorin (LCV) - standard regimen (monthly)
Number of subjects: 47
Study 11128566 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-fluorouracil (5FU) and leucovorin (LCV) - both regimens
Number of subjects: 47
Study 8844445 — intervention group
Group type: EXPERIMENTAL
Intervention: Procanbid (1,000, 2,000, or 4,000 mg/day)
Number of subjects: 43
Study 8844445 — intervention group
Group type: EXPERIMENTAL
Intervention: Procan SR (1,000, 2,000, or 4,000 mg/day)
Number of subjects: 43
Study 8844445 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 43
Study 1470454 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulfacetamide/prednisolone otic drops for 3 days postoperatively
Number of subjects: 430
Study 1470454 — intervention group
Group type: COMPARATOR
Intervention: No drops (control group)
Number of subjects: 430
Study 6387360 — intervention group
Group type: EXPERIMENTAL
Intervention: Viloxazine
Number of subjects: 0
Study 6387360 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 29111902 — intervention group
Group type: EXPERIMENTAL
Intervention: Cranberry juice (240 mL daily)
Number of subjects: 373
Study 29111902 — intervention group
Group type: COMPARATOR
Intervention: Placebo (240 mL daily)
Number of subjects: 373
Study 28383600 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraosseous injection with 4% articaine and 1:100,000 epinephrine
Number of subjects: 70
Study 28383600 — intervention group
Group type: COMPARATOR
Intervention: Inferior alveolar nerve block
Number of subjects: 70
Study 24695100 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-body cryostimulation (WBC) treatments, 30 treatments at -130°C for 3 minutes each
Number of subjects: 45
Study 22544292 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-body MRI (WBMRI)
Number of subjects: 33